Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Raw Materials (2016 - 2018)

Apyx Medical (APYX) has disclosed Raw Materials for 3 consecutive years, with $4.5 million as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Raw Materials fell 12.43% year-over-year to $4.5 million, compared with a TTM value of $4.5 million through Dec 2018, down 12.43%, and an annual FY2018 reading of $4.5 million, down 12.43% over the prior year.
  • Raw Materials was $4.5 million for Q4 2018 at Apyx Medical, down from $5.2 million in the prior quarter.
  • Across five years, Raw Materials topped out at $5.2 million in Q4 2017 and bottomed at $4.5 million in Q4 2016.
  • Average Raw Materials over 3 years is $4.7 million, with a median of $4.5 million recorded in 2016.
  • The sharpest move saw Raw Materials rose 14.2% in 2017, then fell 12.43% in 2018.
  • Year by year, Raw Materials stood at $4.5 million in 2016, then increased by 14.2% to $5.2 million in 2017, then decreased by 12.43% to $4.5 million in 2018.
  • Business Quant data shows Raw Materials for APYX at $4.5 million in Q4 2018, $5.2 million in Q4 2017, and $4.5 million in Q4 2016.